Last reviewed · How we verify

NCT04973514

Perioperative Transfusion Strategies in Adult Congenital Heart Disease Patients Undergoing Cardiac Surgery

Status unknown Last updated 1 April 2022
What this trial tests

trial testing Cardiac surgery in grown-up congenital heart disease patients in Congenital Heart Disease in 500 participants. Status unknown.

Timeline
20 July 2022
Primary endpoint
30 September 2022
30 December 2022

Quick facts

Lead sponsorBrugmann University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment500
Start date20 July 2022
Primary completion30 September 2022
Estimated completion30 December 2022
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Brugmann University Hospital

Who can join

16 and older, any sex, with Congenital Heart Disease or Cardiac Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Due to better medical care, a growing number of patients with congenital heart disease reach adulthood. A large number of these patients needs a redo cardiac surgery. No guidelines of best transfusion practice exist for this patient population. A retrospective analysis of all adult patients with congenital heart disease undergoing cardiac surgery between 2000 and 2020 will be performed. Transfusion practices and their influence on outcome at 30 days and 6 month will be evaluated.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

Other Brugmann University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04973514.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing